ENTITYHealth Care Related OrganizationNeoplastic Process Merck KGaA springs back into M&A game with $3.9B buyout of Pfizer spinout SpringWorks 2 months ago talkbio0Tagged disease treatments, Fibromatosis, Aggressive, Gomekli, KGaA, Merck KGaA, Neurofibromatosis 1, Ogsiveo, Pfizer, Pfizer/, pharmaceutical acquisition, SpringWorks Merck KGaA Acquires SpringWorks Therapeutics for $3.9 Billion Sources: